Drug Shortage Report for TARO-RABEPRAZOLE
| Report ID | 173657 |
| Drug Identification Number | 02298074 |
| Brand name | TARO-RABEPRAZOLE |
| Common or Proper name | RABEPRAZOLE |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RABEPRAZOLE SODIUM |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-27 |
| Estimated end date | 2023-06-30 |
| Actual end date | 2023-06-30 |
| Shortage status | Resolved |
| Updated date | 2023-07-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-11-03 | French | Compare |
| v1 | 2022-11-03 | English | Compare |